| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Meta-Analysis of the Efficacy of Pomalidomide-Based Regimens for the Treatment of Relapsed/Refractory Multiple Myeloma After Lenalidomide Exposure
|
Davies, Faith E.
|
|
|
23 |
11 |
p. 829-837.e1
|
artikel
|
| 2 |
Clinical Application of 18F-FDG-PET Quantification in Hematological Malignancies: Emphasizing Multiple Myeloma, Lymphoma and Chronic Lymphocytic Leukemia
|
Zirakchian Zadeh, Mahdi
|
|
|
23 |
11 |
p. 800-814
|
artikel
|
| 3 |
Clinical Efficacy of Retreatment With Venetoclax-Based Therapy in Relapsed-Refractory t(11;14) Multiple Myeloma
|
Dima, Danai
|
|
|
23 |
11 |
p. 857-860
|
artikel
|
| 4 |
Clinicopathologic Features of Cutaneous T-Cell Lymphomas With Extracutaneous Metastasis: A Case Series
|
Tang, Haiming
|
|
|
23 |
11 |
p. e405-e410
|
artikel
|
| 5 |
Cost of Disease Progression in Diffuse Large B-Cell Lymphoma After Frontline Treatment With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
|
Burke, John M.
|
|
|
23 |
11 |
p. e393-e404
|
artikel
|
| 6 |
Disparities in Multiple Myeloma Treatment Patterns in the United States: A Systematic Review
|
Gasoyan, Hamlet
|
|
|
23 |
11 |
p. e420-e427
|
artikel
|
| 7 |
Disparities in Time to Diagnosis Among Patients With Multiple Myeloma
|
Lin, Olivia M.
|
|
|
23 |
11 |
p. e379-e385
|
artikel
|
| 8 |
Early T-Cell Precursor Leukemia: A High-Risk Subtype of Acute Lymphoblastic Leukemia, Single Center Experience in Jordan
|
Halahleh, Khalid
|
|
|
23 |
11 |
p. e411-e419
|
artikel
|
| 9 |
Editorial Board
|
|
|
|
23 |
11 |
p. A1-A2
|
artikel
|
| 10 |
Expert Consensus on the Incorporation of Anti-CD38 Monoclonal Antibody Therapy Into the Management of Newly Diagnosed Multiple Myeloma
|
Lonial, Sagar
|
|
|
23 |
11 |
p. 815-824
|
artikel
|
| 11 |
Geographic Disparity of Outcome in Patients With Cancer Over Decades: The Surveillance, Epidemiology, and End Results
|
Sasaki, Koji
|
|
|
23 |
11 |
p. e369-e378
|
artikel
|
| 12 |
Long-Term Efficacy of High-Dose Imatinib in Hispanic Patients Without Access to Second-Generation Tyrosine Kinase Inhibitors Treated in LATAM Centers
|
Cantu-Rodriguez, Olga Graciela
|
|
|
23 |
11 |
p. e386-e392
|
artikel
|
| 13 |
Loss of CD34+ Cells and Effect of the Number of Viable Cryopreserved CD34+ Cells in the Infused Blood Grafts on Hematologic Recovery, Progression-Free Survival and Overall Survival in NHL Patients After Autologous Stem Cell Transplantation
|
Partanen, Anu
|
|
|
23 |
11 |
p. e428-e435
|
artikel
|
| 14 |
Real World Efficacy and Toxicity of Selinexor: Importance of Patient Characteristics, Dose Intensity and Post Progression Outcomes
|
Kastritis, Efstathios
|
|
|
23 |
11 |
p. 844-849
|
artikel
|
| 15 |
SOHO State of the Art Updates and Next Questions | Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia in Adults: Therapeutic Options and Challenges in 2023
|
Rahman, Zaid Abdel
|
|
|
23 |
11 |
p. 779-785
|
artikel
|
| 16 |
SOHO State of the Art Updates and Next Questions | Treatment of Richter's Transformation
|
Romano, Ilaria
|
|
|
23 |
11 |
p. 786-799
|
artikel
|
| 17 |
Table of Contents
|
|
|
|
23 |
11 |
p. A3-A5
|
artikel
|
| 18 |
The Impact of CD34+ Cell Collection Yields for Autologous Transplant on Survival Outcomes in Multiple Myeloma
|
Lebel, Eyal
|
|
|
23 |
11 |
p. 850-856
|
artikel
|
| 19 |
Venous Thromboembolism Risk in Patients With Newly Diagnosed Multiple Myeloma Treated with Carfilzomib or Bortezomib in Combination With Lenalidomide and Dexamethasone
|
Loncharich, Alexa J.
|
|
|
23 |
11 |
p. 825-828
|
artikel
|
| 20 |
Very late relapse in Hodgkin lymphoma: Characterizing an understudied population
|
Cherniawsky, Hannah
|
|
|
23 |
11 |
p. 838-843
|
artikel
|
Tijdschrift beschrijving